Navigation Links
Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
Date:12/15/2009

NEW HAVEN, Conn., Dec. 15 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections announced today it has entered into a collaborative research agreement with Massachusetts General Hospital (MGH).

Under the science plan for the collaboration, Dr. David Hooper of MGH will evaluate Rib-X's novel fluoroquinolone, delafloxacin, in an established animal model to determine resistance development and to validate the activity and mechanism of action of delafloxacin against microorganisms such as methicillin-resistant Staphylococcus aureus (MRSA).

"Treating infections that are resistant to the antibiotics currently available to us has become increasingly challenging," Dr. Hooper said. "We are interested to learn more about the unusual properties of this specific drug relative to other members of its class and its potential effect on controlling difficult and dangerous infections."

Delafloxacin, which is ready to enter Phase 3 clinical trials, is a novel, broad-spectrum, next-generation fluoroquinolone, that has demonstrated better activity than other quinolones against Gram-positive bacteria, including isolates of MRSA that are quinolone-resistant.

"The opportunity to work with Dr. David Hooper on the in vivo mechanism of action of delafloxacin is a very important extension of the research we have done here at Rib-X," said Susan Froshauer, Ph.D., Rib-X's President and CEO. "Dr. Hooper is a well-known expert on fluoroquinolones and this collaboration will demonstrate the potential for delafloxacin to take its place in the arsenal of drugs for battling recalcitrant quinolone-resistant infections."

Rib-X previously announced positive results from a Phase 2 trial utilizing the IV formulation of delafloxacin in complicated skin and skin structure infections (cSS
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology
2. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
3. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
4. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
7. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
8. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
9. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
10. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
11. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Levi & Korsinsky is investigating the Board of ... BIIB) for possible violations of federal securities laws. The ... and/or directors have violated Sections 10(b) and 20(a) of ... 24, 2015, prior to the opening of the market, ... other things, the Company lowered its prior revenue guidance ...
(Date:8/4/2015)... -- The Pittsburgh Life Sciences Greenhouse (PLSG), the region,s only ... of its portfolio companies, Medrobotics Corporation, has received FDA ... System in the U.S.  "I couldn,t ... John W. Manzetti , president and CEO of ... spinning out of The Robotics Institute at Carnegie Mellon ...
(Date:8/4/2015)... Aug. 4, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August ... Parker Meridien in New York . ... www.meipharma.com . A replay will be available approximately one ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2
... NEW YORK, Feb. 16, 2012 Delcath Systems, Inc. (NASDAQ: ... entered into an initial launch and training agreement for the ... Center Schleswig-Holstein (Kiel Campus), one of the largest European centers ... to commercially utilize the CHEMOSAT system to treat patients. Under ...
... Inc., a leading provider of revenue and payment ... announced a clinical services agreement with Informatics Corporation ... and results as well as EHR capabilities. ... developed by Vanderbilt Medical Center in Nashville, Tennessee, ...
Cached Medicine Technology:Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 2Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 3Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 4Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 2Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 3Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 4Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 5
(Date:8/5/2015)... , ... August 05, 2015 , ... HealthyYOU Vending says ... campaign by the City & County of San Francisco are representative of initiatives ... M. Lee recently approved a measure from the City and County of San Francisco ...
(Date:8/5/2015)... ... August 05, 2015 , ... The President ... honored as one of this year’s 50 Most Influential Women in Arizona by ... business. Carol May’s long-standing dedication to the well-being of consumers through Wisdom Natural ...
(Date:8/4/2015)... ... August 05, 2015 , ... ... Stevens as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting more than ...
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain Research has ... corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain are serious public ... say that one causes the other. Rather, there appear to be multiple factors that ...
(Date:8/4/2015)... ... August 04, 2015 , ... assistPoint Partners, LLC ... consolidate oncology patient assistance programs. Through a secure web portal, assistPoint connects Life ... an enterprise level, cloud-based application and workflow solution. This provides cancer center patient ...
Breaking Medicine News(10 mins):Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 2Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 3Health News:Carol May Named One of the Most Influential Woman in Arizona 2Health News:Carol May Named One of the Most Influential Woman in Arizona 3Health News:Carol May Named One of the Most Influential Woman in Arizona 4Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:assistPoint.com Web Site Launched 2
... puzzling over the case of 44-year-old civil servant who has ... tiny brain . ,In a case history published ... the Hopital de la Timone in Marseille say the father-of-two ... left leg. ,Scans by computed tomography (CT) and ...
... an issue for every country and ultimately, for every food ... incidents that occurred in the last 12 months, two agencies ... when dealing with traders and producers that affect the supply ... Organization (FAO) and the World Health Organization (WHO) cited the ...
... star this week for allegedly organizing illegal dog fights has ... attracting an increasingly wide following. ,The blood ... illegal in all 50 states, but can be found across ... very prevalent in the South now it's all over, in ...
... the University Clinic of the University of Navarra have ... adult stem cell growth for its capacity to ... ,Ana Fernandez Hortelano, ophthalmologist at the hospital, applied ... cornea in 70 rabbits for the purpose of regaining ...
... containing HIV but must remove the stigma associated with the ... control, international research chiefs say. ,Speaking ahead ... next week, America's top expert Anthony Fauci and his Australian ... risk in Asia. ,Fauci said predictions HIV would ...
... drug proven effective in preventing prostate cancer, just because it ... now put their fears to rest, thanks to a new ... Oncology Group, found that though the drug does cause a ... of time. ,As a part of their study, ...
Cached Medicine News:Health News:Gaps In Food Safety Systems Must Be Plugged :UN 2Health News:Dog Fighting in the US: Bloody, Illegal and Booming 2Health News:Asia Must Overcome HIV Stigma, Say Research Chiefs 2Health News:Asia Must Overcome HIV Stigma, Say Research Chiefs 3Health News:Mens Sexual Prowess Not Affected by Prostate Cancer Drug 2
The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...
... StelKast's Proven™ knee system ... solution based on a clinically ... posterior stabilized and anatomically correct ... instrument standardization and ease of ...
... Oxinium (oxidized zirconium) isn't a new implant. ... Smith & Nephew. Wear debris can be ... almost nil, addressing the needs of the ... are all improved. Initially, Oxinium is available ...
The RT-PLUS Solution is an axially supported rotation knee prosthesis for cemented implantation. The implant is available in three sizes, each of which can be combined with the next size up or down....
Medicine Products: